Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias

Department of Cardiology, Guy's Hospital, Guy's and St. Thomas' NHS Trust, London, England, United Kingdom.

OBJECTIVES: We sought 1) to compare three pacing modalities-DDDR with mode switching (DM), DDDR with conventional upper rate behavior (DR) and VVIR (VR)-in patients with a history of atrial tachyarrhythmias, and 2) to assess the efficacy of six mode-switching algorithms. BACKGROUND: A history of atrial tachyarrhythmias has been a relative contraindication to dual-chamber pacing. Several mode-switching algorithms have recently been developed to prevent rapid tracking of atrial tachyarrhythmias. METHODS: Forty-eight patients (mean age 64 years, 58% male) with a history of atrial tachyarrhythmias and heart block had a DM pacemaker implanted. Pacemakers were programmed to DM, DR and VR modes for 4 weeks each in a randomized crossover design. All subjects used a patient-activated electrocardiographic (ECG) recorder throughout the study and additionally underwent ambulatory ECG monitoring and a treadmill exercise test in each mode. They completed three symptom questionnaires at the end of each pacing period. At the end of the study, patients chose their preferred pacing period. RESULTS: DM was significantly better than VR mode objectively (exercise time DM 8.1 min, VR 7.0 min, p < 0.01) and subjectively (perceived well-being DM 69, VR 51, p < 0.001; functional class DM 2.2, VR 2.5, p < 0.05; subjective symptom score DM 21.2, VR 26.8, p = 0.01). Patient-perceived well-being was significantly better with DM than with DR mode (DM 69, DR 60, p = 0.02). DM mode was the preferred pacing period (DM 51%, DR 14%, VR 14%). Early termination of pacing because of adverse symptoms was requested by 33% of patients during VR, 19% during DR but only 3% during DM mode. A higher proportion of patients with a fast mode-switching device preferred DM mode (fast 55%, slow 49%), whereas no patients with a fast mode-switching device chose VR as the preferred mode (fast 0%, slow 19%). In the subgroup of patients who had had atrioventricular node ablation, DM was also preferred to VR mode (DM 53%, VR 27%). Overall, there were only two cases of inappropriate mode switching and one case of inappropriate tracking of an atrial tachyarrhythmia. CONCLUSIONS: DM is the pacing mode of choice of patients with paroxysmal atrial tachyarrhythmias. With optimal programming, inappropriate mode switching and tracking of atrial tachyarrhythmias was very uncommon.

This article has been cited by other articles:

				C. M. Fored, F. Granath, F. Gadler, P. Blomqvist, J. Rynder, C. Linde, A. Ekbom, and M. Rosenqvist Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study Europace, July 1, 2008; 10(7): 825 - 831. [Abstract] [Full Text] [PDF]

				T. R. Betts Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients Europace, April 1, 2008; 10(4): 425 - 432. [Abstract] [Full Text] [PDF]

				J. Chen, C. de Chillou, O-J. Ohm, P. I. Hoff, O. Rossvoll, M. Andronache, N. Sadoul, I. Magnin-Poull, K. S. Erga, and E. Aliot Acute resumption of conduction in the cavotricuspid isthmus after catheter ablation in patients with common atrial flutter: Real-time evaluation and long-term follow-up Europace, January 1, 2002; 4(3): 255 - 263. [Abstract] [PDF]

				K. J. Ward, J. E. Willett, C. Bucknall, J. S. Gill, and K. Kamalvand Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment Europace, January 1, 2001; 3(2): 108 - 114. [Abstract] [PDF]

				C. D. Swerdlow, W. Schsls, B. Dijkman, W. Jung, N. V. Sheth, W. H. Olson, B. D. Gunderson, and f. t. W. J. A. Investigators Detection of Atrial Fibrillation and Flutter by a Dual-Chamber Implantable Cardioverter-Defibrillator Circulation, February 29, 2000; 101(8): 878 - 885. [Abstract] [Full Text] [PDF]

				H. J. Marshall, Z. I. Harris, M. J. Griffith, R. L. Holder, and M. D. Gammage Prospective Randomized Study of Ablation and Pacing Versus Medical Therapy for Paroxysmal Atrial Fibrillation : Effects of Pacing Mode and Mode-Switch Algorithm Circulation, March 30, 1999; 99(12): 1587 - 1592. [Abstract] [Full Text] [PDF]

				M. Brignole, M. Gammage, L. Jordaens, R. Sutton, and on behalf of the Barcelona Discussion Group Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation Europace, January 1, 1999; 1(1): 8 - 13. [Abstract] [PDF]

				M. Brignole, L. Gianfranchi, C. Menozzi, P. Alboni, G. Musso, M. G. Bongiorni, M. Gasparini, A. Raviele, G. Lolli, N. Paparella, et al. Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation: The PAF study Europace, January 1, 1999; 1(1): 15 - 19. [Abstract] [PDF]

				H.J. Marshall, G.N. Kay, M. Hess, V.J. Plumb, R.S. Bubien, J. Hummel, D. Dawson, T. Markewitz, and M.D. Gammage Mode switching in dual chamber pacemakers: Effect of onset criteria on arrhythmia-related symptoms Europace, January 1, 1999; 1(1): 49 - 54. [Abstract] [PDF]

				J.C. Nielsen, A.K. Pedersen, P.T. Mortensen, and H.R. Andersen Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome Europace, January 1, 1999; 1(2): 113 - 120. [Abstract] [PDF]

				H. J. Marshall, M. J. Griffith, and M. D. Gammage Placement of atrial pacing leads during atrial fibrillation: Feasibility and subsequent lead performance Europace, January 1, 1999; 1(2): 131 - 134. [Abstract] [PDF]

				J. Neuzner, J. Sperzel, H. F. Pitschner, T. Schwarz, W. Ehrlich, B. Schulte, and W. Haberbosch Bipolar atrial sensing thresholds in sinus rhythm and atrial tachyarrhythmias: A comparative analysis in patients with DDDR pacemakers Europace, January 1, 1999; 1(2): 135 - 139. [Abstract] [PDF]

				F. Bellocci, A. Spampinato, R. Ricci, A. Puglisi, A. Capucci, P. Dini, G. Boriani, G. Botto, A. Curnis, P.V. Moracchini, et al. Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: A prospective, multicentre study Europace, January 1, 1999; 1(4): 220 - 225. [Abstract] [PDF]

				M BRIGNOLE Ablate and pace: a pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs Heart, June 1, 1998; 79(6): 531 - 533. [Full Text]

				G M Gribbin, J P Bourke, and J M McComb Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias Heart, June 1, 1998; 79(6): 548 - 553. [Abstract] [Full Text]